Marine medicine
A new report has identified three marine organisms that may be useful for biomedical research, potentially leading to new treatments for human diseases.
The US Department of the Interior’s Minerals Management Service (MMS) has released a report that identifies three marine organisms that may be useful for biomedical research - potentially leading to new treatments for human diseases.
Under a research agreement sponsored by MMS, University of California at Santa Barbara (UCSB) researchers studied marine organisms collected from offshore oil and gas platforms in California’s Santa Barbara Channel and found that two invertebrate species contain compounds that inhibit the division of cancer cells grown in the laboratory.
Additionally, a compound isolated from algae collected from oil platforms in the Gulf of Mexico has been shown to block cell division and enhance the activity of the cancer drug Taxol.
The report is the result of a research initiative between the MMS and UCSB that examined pharmaceutical applications of marine organisms growing on offshore oil and gas structures along California’s coast.
The compound produced by the algae may have similar activities that would make it a candidate for use as a cancer chemotherapeutic.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
CCC Report Finds UK Climate Targets Still Within Reach
In 1990 67% of the UK´s electricity came from coal-fired power stations and even without renewables the transition to gas was a major contributor to...